Biogen agrees to acquire neurological complaint specialist Reata Pharmaceuticals at 60 decoration
BioGen to Acquire Neurological complaint Specialist Reta Pharmaceuticals at a 60 Premium In its hunt for a deal that has been going on for months, BioGen( NASDAQ BIIB) has made…